22 Jan 2020 – Proactive interview – Destiny Pharma awaits key inflection point mid-2020 in its antimicrobial Phase 2b clinical trial

Destiny Pharma CEO, Neil Clark, spoke with Proactive at the Biotech Showcase 2020 in San Francisco.  Please click here for video.